SNGX
SNGX
NASDAQ · Biotechnology

Soligenix Inc

$0.38
-0.01 (-1.80%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +10,718.8% upside
Low Target $24.77
Average Target $40.83
High Target $47.84
Current Price $0.38
Current
$0.38
Target
$40.83
$24.77 $40.83 avg $47.84
Scenario Analysis
Bear Case
$24.77
6,463.3%
Low target
Base Case
$40.83
+10,718.8%
Avg target
Bull Case
$47.84
+12,576.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.00
-81.1% from high
52-Week Low
$0.28
+34.8% from low
Target vs 52W High
$40.83
+1,941.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%